Article
Study shows moxifloxacin safe in treatment of bacterial conjunctivitis
Ft. Lauderdale-Results of an FDA Phase III study demonstrate that moxifloxacin ophthalmic solution 0.5% (Vigamox, Alcon) is a safe and effective treatment for bacterial conjunctivitis in adults and children as young as 1 month old, said Harold R. Katz, MD, speaking on behalf of the Moxifloxacin Conjunctivitis Study Group.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
